Hong Kong Food Stock News

SEHK:2616
SEHK:2616Biotechs

A Look At CStone Pharmaceuticals (SEHK:2616) Valuation After Encouraging CS2009 Trial Results And Wider Losses

CStone Pharmaceuticals (SEHK:2616) has drawn fresh attention after reporting detailed Phase I/II data for CS2009, its trispecific antibody, alongside full year 2025 results that show CNY 269.58 million in sales and a CNY 437 million net loss. See our latest analysis for CStone Pharmaceuticals. The encouraging CS2009 data appears to be feeding into a strong shift in sentiment, with a 1 day share price return of 5.04% and a 7 day share price return of 40.68% at HK$8.75. Momentum has been...
SEHK:1378
SEHK:1378Metals and Mining

China Hongqiao Group (SEHK:1378) Is Up 12.9% After Lifting Its Final Dividend Proposal – Has The Bull Case Changed?

China Hongqiao Group reported its full-year 2025 results on 20 March 2026, with sales of CNY 162.35 billion and net income of CNY 22.64 billion, and proposed a final ordinary dividend of HK$1.65 per share for shareholder approval in May 2026. Alongside steady earnings, the company’s decision to raise its final dividend payout highlights a focus on returning cash to shareholders while maintaining operational scale. We will now examine how China Hongqiao Group’s higher final dividend proposal...